Maeve O'Meara - 21 Mar 2022 Form 4 Insider Report for Oncology Institute, Inc. (TOI)

Role
Director
Signature
/s/ Mark Hueppelsheuser, Attorney-in-Fact for Maeve O'Meara
Issuer symbol
TOI
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4
Filing time
23 Mar 2022, 19:36:34 UTC
Previous filing
18 Feb 2022
Next filing
21 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TOI Common stock Award $0 +15,994 $0.000000 15,994 21 Mar 2022 Direct F1
transaction TOI Common stock Award $0 +3,998 +25% $0.000000 19,992 21 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date.